WeVote
Log In

Bill

Bill

SB 483

AN ACT IMPLEMENTING THE RECOMMENDATIONS OF THE NONALCOHOLIC STEATOHEPATITIS TASK FORCE.

2025 Regular Session Introduced by Saud Anwar

Connecticut bill implements NASH Task Force recommendations to improve nonalcoholic steatohepatitis prevention, screening, and treatment across state healthcare systems.

REF. TO JOINT COMM. ON Public Health
#taskforces
0
WeVote Research Nonpartisan
Bill Summary · SB 483

Legislative bill overview

SB 483 implements recommendations from Connecticut's Nonalcoholic Steatohepatitis (NASH) Task Force, which likely addresses prevention, screening, and treatment protocols for NASH—a serious liver disease affecting millions without hepatitis. The bill translates task force findings into actionable state policy, potentially including healthcare system changes, provider education, and patient awareness initiatives.

Why is this important

NASH is a progressive liver condition increasingly common in the U.S. due to obesity and metabolic syndrome, yet many patients remain undiagnosed until advanced stages. Connecticut's implementation of coordinated recommendations could improve early detection, reduce liver disease mortality, and potentially lower long-term healthcare costs by preventing cirrhosis and transplant needs.

Potential points of contention

  • Healthcare provider burden: New screening or reporting requirements may increase workload for primary care physicians and specialists without corresponding reimbursement or staffing resources
  • Insurance coverage: Expanded NASH diagnostic testing and treatment protocols could face pushback from insurers regarding cost-sharing or coverage limitations
  • Task force scope: Disagreement may exist over whether recommendations prioritize prevention (lifestyle changes, public health) versus clinical intervention (medications, specialist care)

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.